Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis

Fig. 1

Urea cycle and dimethylarginine metabolic pathways. a l-Arginine is the common substrate of arginase and nitric oxide synthase (NOS). Asymmetric dimethylarginine (ADMA) and l-NG-monomethyl arginine (MMA) are potent inhibitors of NOS, whereas symmetric dimethylarginine (SDMA) inhibits nitric oxide (NO) production by inhibiting l-arginine cellular uptake. b Schematic diagram showing the pathways that produce methylated arginines (MMA, ADMA, and SDMA). PRMT Protein arginine methyltransferase

Back to article page